Skip to main content
Equibles
TARS $73.00 -3.26%
TARS logo
TARS · Tarsus Pharmaceuticals, Inc.
Track TARS — free

Use TARS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TARS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$73.00 -2.46 (-3.26%)
Russell 2000 member Rebalance outlook locked
Market Cap
$3.32B
Shares
43.88M
Volume · Oct 2 805.7K Avg daily vol (3M) 943.54K
All webcasts

Earnings call · FY2023 Q1

Tarsus Pharmaceuticals, Inc. (TARS) Q1 2023 Earnings Call

Concluded May 9, 2023
May 9, 2023 0 turns
Period
FY2023 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $2.50M +363.8% YoY
Diluted EPS -$0.88
Net income -$23.42M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 9, 2023 10-Q report Filed May 9, 2023

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License and Collaboration$2.50M +363.8% YoY
License and Collaboration Other$0
Product$0
Full-screen source Call document

TARS transcript alerts

Tarsus Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →